Are you Dr. Feany?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-7510
Summary
- Dr. Mel Feany, MD is a board certified pathologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Hospital and is a Professor at Harvard Medical School.
Education & Training
Brigham and Women's HospitalFellowship, Neuropathology, 1997 - 1999- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
Albert Einstein College of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 1999 - 2025- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 70 citationsInactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington’s disease modelSheng Zhang, Mel B. Feany, Sudipta Saraswati, J. Troy Littleton, Norbert Perrimon
Disease Models & Mechanisms. 2009-05-01 - 225 citationsCathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivoValerie Cullen, Maria Lindfors, Juliana Ng, Anders Paetau, Erika Swinton
Molecular Brain. 2009-02-09 - 1521 citationsA Drosophila model of Parkinson's diseaseMel B. Feany, Welcome Bender
Nature. 2000-03-23
Press Mentions
Cross-Species Strategy Might Be a Powerful Tool for Studying Human DiseaseFebruary 4th, 2011
New Parkinson’s Research Center to Open at YaleNovember 4th, 2023
Grant Support
- Pharmacological Modulation Of TAU Neurotoxicity In VivoNational Institute On Aging2011
- Mechanisms Underlying Neuronal Cell Type Specificity In NeurodegenerationNational Institute On Aging2008–2011
- Chemical Modulation Of Lysosomal Storage In VivoNational Institute Of Neurological Disorders And Stroke2009–2010
- Drosophila Models Of Alexander DiseaseNational Institute Of Neurological Disorders And Stroke2008–2009
- Phosphorylation Control Of TAU Neurotoxicity In DrosophilaNational Institute On Aging2007–2008
- Aging In Drosophila Models Of Human NeurodegenerationNational Institute On Aging2006–2007
- Drosophila Model Of Amyotrophic Lateral SclerosisNational Institute Of Neurological Disorders And Stroke2004–2007
- Phosphorylation Control--Tau Neurotoxicity In DrosophilaNational Institute On Aging2004–2006
- Genetic Dissection Of Neurodegenerative DementiasNational Institute On Aging2001–2005
- Drosophila Model Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2001–2005
- Genetic Model Of NeurodegenerationNational Institute On Aging1998–2003
